2021
Addressing psychosocial health in the treatment and care of adolescents with obesity
Jebeile H, Cardel MI, Kyle TK, Jastreboff AM. Addressing psychosocial health in the treatment and care of adolescents with obesity. Obesity 2021, 29: 1413-1422. PMID: 34431234, DOI: 10.1002/oby.23194.Peer-Reviewed Original ResearchConceptsPsychosocial healthPsychosocial outcomesMajority of adolescentsCare of adolescentsBody imagePsychological supportPsychosocial impactObesity treatment interventionsAdolescentsTreatment interventionsSelf-directed weight lossFuture researchPsychosocial comorbiditiesReduced symptomsWeight management optionsMulticomponent interventionWeight lossFurther weight gainQuality of lifeTreatment servicesObesity treatmentImpact of interventionsInterventionAntiobesity pharmacotherapiesObesity care
2012
Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies
Woods SW, Walsh BC, Hawkins KA, Miller TJ, Saksa JR, D'Souza DC, Pearlson GD, Javitt DC, McGlashan TH, Krystal JH. Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies. European Neuropsychopharmacology 2012, 23: 931-940. PMID: 23089076, PMCID: PMC4028140, DOI: 10.1016/j.euroneuro.2012.09.008.Peer-Reviewed Original ResearchConceptsPilot studyRisk syndromeSyndrome patientsNegative symptomsShort-term pilot studyEffect sizeAdjunctive antipsychotic medicationOpen-label studyPatients meeting criteriaNMDA receptor functionDurability of effectPsychosis risk symptomsGlycine site agonistsGroup effect sizesWeeks of evaluationAntipsychotic medicationSyndrome subjectsPromising effect sizesTreatment needsLarge effect sizesMeeting criteriaCognitive impairmentReduced symptomsReceptor functionSymptoms
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply